Phenyl or pyridinyl substituted indazoles derivatives

Details for Australian Patent Application No. 2009249872 (hide)

Owner AstraZeneca AB

Inventors Hemmerling, Martin; Edman Karl; Nilsson, Stinabritt; Hossain, Nafizal; Berger, Markus; Johansson, Henrik; Rehwinkel, Hartmut; Hansson, Thomas; Lepisto, Matti; Dahmen, Jan

Agent Freehills

Pub. Number AU-A-2009249872

PCT Pub. Number WO2009/142569

Priority 61/144,776 15.01.09 US; 61/080,312 14.07.08 US; 61/054,616 20.05.08 US

Filing date 20 May 2009

Wipo publication date 26 November 2009

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/142569 Priority application(s): WO2009/142569

9 December 2010 Alteration of Name

  The name of the applicant has been altered to AstraZeneca AB; Bayer Schering Pharma AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009249874-Phenyl and benzodioxinyl substituted indazoles derivatives

2009249867-Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system